Clinical Trials Logo

Activated PI3K-delta Syndrome clinical trials

View clinical trials related to Activated PI3K-delta Syndrome.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03383380 Recruiting - Clinical trials for Activated PI3K-delta Syndrome

Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome

Start date: December 1, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this proposed research is to evaluate the efficacy and safety of the rapamycin therapy in patients with activated phosphoinositide 3-kinase δ syndrome (APDS).